25 XP   0   0   10

Jiangxi Fushine Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Fushine together

PenkeI guess you are interested in Jiangxi Fushine Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Jiangxi Fushine Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Jiangxi Fushine Pharmaceutical Co Ltd

I send you an email if I find something interesting about Jiangxi Fushine Pharmaceutical Co Ltd.

Quick analysis of Fushine (30 sec.)










What can you expect buying and holding a share of Fushine? (30 sec.)

How much money do you get?

How much money do you get?
¥0.05
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥4.89
Expected worth in 1 year
¥3.28
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
¥-1.22
Return On Investment
-13.5%

For what price can you sell your share?

Current Price per Share
¥9.02
Expected price per share
¥5.62 - ¥11.27
How sure are you?
50%

1. Valuation of Fushine (5 min.)




Live pricePrice per Share (EOD)

¥9.02

Intrinsic Value Per Share

¥-18.89 - ¥-6.46

Total Value Per Share

¥-14.00 - ¥-1.56

2. Growth of Fushine (5 min.)




Is Fushine growing?

Current yearPrevious yearGrowGrow %
How rich?$371.1m$401.7m-$30.5m-8.2%

How much money is Fushine making?

Current yearPrevious yearGrowGrow %
Making money-$19.5m$6.7m-$26.2m-134.5%
Net Profit Margin-8.6%3.4%--

How much money comes from the company's main activities?

3. Financial Health of Fushine (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#150 / 1010

Most Revenue
#61 / 1010

Most Profit
#693 / 1010

Most Efficient
#461 / 1010

What can you expect buying and holding a share of Fushine? (5 min.)

Welcome investor! Fushine's management wants to use your money to grow the business. In return you get a share of Fushine.

What can you expect buying and holding a share of Fushine?

First you should know what it really means to hold a share of Fushine. And how you can make/lose money.

Speculation

The Price per Share of Fushine is ¥9.02. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Fushine.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Fushine, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥4.89. Based on the TTM, the Book Value Change Per Share is ¥-0.40 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.25 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.10 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Fushine.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps-0.04-0.4%-0.04-0.4%0.010.1%0.040.4%0.030.3%
Usd Book Value Change Per Share-0.06-0.6%-0.06-0.6%-0.03-0.4%0.091.0%0.060.7%
Usd Dividend Per Share0.010.2%0.010.2%0.030.4%0.020.2%0.020.2%
Usd Total Gains Per Share-0.04-0.5%-0.04-0.5%0.000.0%0.111.2%0.080.9%
Usd Price Per Share1.82-1.82-2.25-1.80-1.89-
Price to Earnings Ratio-51.32--51.32-183.93-41.02-49.17-
Price-to-Total Gains Ratio-43.45--43.45-3,268.32-652.78-426.55-
Price to Book Ratio2.70-2.70-3.09-3.43-6.99-
Price-to-Total Gains Ratio-43.45--43.45-3,268.32-652.78-426.55-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.24476
Number of shares803
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.02
Usd Book Value Change Per Share-0.060.09
Usd Total Gains Per Share-0.040.11
Gains per Quarter (803 shares)-33.6686.91
Gains per Year (803 shares)-134.66347.64
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
144-179-14570278338
288-357-280140555686
3132-536-4152108331034
4176-715-55028011111382
5220-893-68535013891730
6264-1072-82042016662078
7308-1251-95549019442426
8352-1429-109055922222774
9396-1608-122562924993122
10440-1786-136069927773470

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%7.01.02.070.0%7.01.04.058.3%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%8.02.00.080.0%10.02.00.083.3%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%12.00.00.0100.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%11.01.00.091.7%

Fundamentals of Fushine

About Jiangxi Fushine Pharmaceutical Co Ltd

Jiangxi Fushine Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of APIs and pharmaceutical intermediates in China and internationally. The company offers penicillin, carbapenem, and other products, as well as intermediates of antiviral drugs. It also provides contract research, development, and manufacturing services, as well as engages in lithium battery electrolyte additives. The company was formerly known as Jingdezhen Fuxiang Pharmaceutical Co., Ltd and changed its name to Jiangxi Fushine Pharmaceutical Co., Ltd. in August 2012. Jiangxi Fushine Pharmaceutical Co., Ltd. was founded in 2002 and is based in Jingdezhen, China.

Fundamental data was last updated by Penke on 2024-04-16 15:36:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Jiangxi Fushine Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Fushine earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Fushine to the Biotechnology industry mean.
  • A Net Profit Margin of -8.6% means that ¥-0.09 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Jiangxi Fushine Pharmaceutical Co Ltd:

  • The MRQ is -8.6%. The company is making a loss. -1
  • The TTM is -8.6%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-8.6%TTM-8.6%0.0%
TTM-8.6%YOY3.4%-12.0%
TTM-8.6%5Y11.1%-19.7%
5Y11.1%10Y11.3%-0.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.6%-200.1%+191.5%
TTM-8.6%-216.8%+208.2%
YOY3.4%-288.3%+291.7%
5Y11.1%-449.1%+460.2%
10Y11.3%-605.5%+616.8%
1.1.2. Return on Assets

Shows how efficient Fushine is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Fushine to the Biotechnology industry mean.
  • -2.8% Return on Assets means that Fushine generated ¥-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Jiangxi Fushine Pharmaceutical Co Ltd:

  • The MRQ is -2.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.8%TTM-2.8%0.0%
TTM-2.8%YOY1.0%-3.8%
TTM-2.8%5Y5.4%-8.2%
5Y5.4%10Y5.8%-0.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.8%-13.3%+10.5%
TTM-2.8%-12.8%+10.0%
YOY1.0%-11.7%+12.7%
5Y5.4%-13.9%+19.3%
10Y5.8%-15.7%+21.5%
1.1.3. Return on Equity

Shows how efficient Fushine is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Fushine to the Biotechnology industry mean.
  • -5.3% Return on Equity means Fushine generated ¥-0.05 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Jiangxi Fushine Pharmaceutical Co Ltd:

  • The MRQ is -5.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -5.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.3%TTM-5.3%0.0%
TTM-5.3%YOY1.7%-7.0%
TTM-5.3%5Y9.0%-14.3%
5Y9.0%10Y10.3%-1.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.3%-16.9%+11.6%
TTM-5.3%-16.1%+10.8%
YOY1.7%-15.1%+16.8%
5Y9.0%-19.3%+28.3%
10Y10.3%-20.2%+30.5%

1.2. Operating Efficiency of Jiangxi Fushine Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Fushine is operating .

  • Measures how much profit Fushine makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Fushine to the Biotechnology industry mean.
  • An Operating Margin of -3.6% means the company generated ¥-0.04  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Jiangxi Fushine Pharmaceutical Co Ltd:

  • The MRQ is -3.6%. The company is operating very inefficient. -2
  • The TTM is -3.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-3.6%TTM-3.6%0.0%
TTM-3.6%YOY14.4%-18.1%
TTM-3.6%5Y17.3%-20.9%
5Y17.3%10Y16.1%+1.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.6%-296.2%+292.6%
TTM-3.6%-232.5%+228.9%
YOY14.4%-298.2%+312.6%
5Y17.3%-492.1%+509.4%
10Y16.1%-632.4%+648.5%
1.2.2. Operating Ratio

Measures how efficient Fushine is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.80 means that the operating costs are ¥1.80 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Jiangxi Fushine Pharmaceutical Co Ltd:

  • The MRQ is 1.797. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.797. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.797TTM1.7970.000
TTM1.797YOY1.551+0.246
TTM1.7975Y1.465+0.331
5Y1.46510Y1.289+0.176
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7973.231-1.434
TTM1.7973.310-1.513
YOY1.5513.890-2.339
5Y1.4655.739-4.274
10Y1.2897.876-6.587

1.3. Liquidity of Jiangxi Fushine Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Fushine is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.77 means the company has ¥1.77 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Jiangxi Fushine Pharmaceutical Co Ltd:

  • The MRQ is 1.771. The company is able to pay all its short-term debts. +1
  • The TTM is 1.771. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.771TTM1.7710.000
TTM1.771YOY1.700+0.071
TTM1.7715Y1.872-0.101
5Y1.87210Y1.463+0.409
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7713.890-2.119
TTM1.7714.173-2.402
YOY1.7005.344-3.644
5Y1.8726.126-4.254
10Y1.4636.448-4.985
1.3.2. Quick Ratio

Measures if Fushine is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Fushine to the Biotechnology industry mean.
  • A Quick Ratio of 0.27 means the company can pay off ¥0.27 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Jiangxi Fushine Pharmaceutical Co Ltd:

  • The MRQ is 0.271. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.271. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.271TTM0.2710.000
TTM0.271YOY0.446-0.175
TTM0.2715Y0.352-0.081
5Y0.35210Y0.408-0.056
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2713.514-3.243
TTM0.2713.998-3.727
YOY0.4465.380-4.934
5Y0.3526.105-5.753
10Y0.4086.404-5.996

1.4. Solvency of Jiangxi Fushine Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Fushine assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Fushine to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.47 means that Fushine assets are financed with 46.8% credit (debt) and the remaining percentage (100% - 46.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Jiangxi Fushine Pharmaceutical Co Ltd:

  • The MRQ is 0.468. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.468. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.468TTM0.4680.000
TTM0.468YOY0.378+0.091
TTM0.4685Y0.396+0.072
5Y0.39610Y0.442-0.045
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4680.339+0.129
TTM0.4680.336+0.132
YOY0.3780.271+0.107
5Y0.3960.366+0.030
10Y0.4420.389+0.053
1.4.2. Debt to Equity Ratio

Measures if Fushine is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Fushine to the Biotechnology industry mean.
  • A Debt to Equity ratio of 88.4% means that company has ¥0.88 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Jiangxi Fushine Pharmaceutical Co Ltd:

  • The MRQ is 0.884. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.884. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.884TTM0.8840.000
TTM0.884YOY0.614+0.270
TTM0.8845Y0.697+0.187
5Y0.69710Y0.846-0.148
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8840.388+0.496
TTM0.8840.402+0.482
YOY0.6140.335+0.279
5Y0.6970.426+0.271
10Y0.8460.461+0.385

2. Market Valuation of Jiangxi Fushine Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Fushine generates.

  • Above 15 is considered overpriced but always compare Fushine to the Biotechnology industry mean.
  • A PE ratio of -51.32 means the investor is paying ¥-51.32 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Jiangxi Fushine Pharmaceutical Co Ltd:

  • The EOD is -35.067. Based on the earnings, the company is expensive. -2
  • The MRQ is -51.318. Based on the earnings, the company is expensive. -2
  • The TTM is -51.318. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-35.067MRQ-51.318+16.251
MRQ-51.318TTM-51.3180.000
TTM-51.318YOY183.933-235.252
TTM-51.3185Y41.024-92.342
5Y41.02410Y49.170-8.146
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-35.067-2.264-32.803
MRQ-51.318-2.629-48.689
TTM-51.318-2.680-48.638
YOY183.933-4.145+188.078
5Y41.024-6.257+47.281
10Y49.170-6.254+55.424
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Jiangxi Fushine Pharmaceutical Co Ltd:

  • The EOD is -8.550. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -12.512. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -12.512. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.550MRQ-12.512+3.962
MRQ-12.512TTM-12.5120.000
TTM-12.512YOY-14.790+2.278
TTM-12.5125Y157.298-169.810
5Y157.29810Y4,769.996-4,612.698
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-8.550-2.973-5.577
MRQ-12.512-3.333-9.179
TTM-12.512-3.553-8.959
YOY-14.790-5.605-9.185
5Y157.298-8.376+165.674
10Y4,769.996-8.865+4,778.861
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Fushine is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.70 means the investor is paying ¥2.70 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Jiangxi Fushine Pharmaceutical Co Ltd:

  • The EOD is 1.845. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.699. Based on the equity, the company is underpriced. +1
  • The TTM is 2.699. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.845MRQ2.699-0.855
MRQ2.699TTM2.6990.000
TTM2.699YOY3.085-0.386
TTM2.6995Y3.429-0.729
5Y3.42910Y6.993-3.564
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.8451.896-0.051
MRQ2.6992.115+0.584
TTM2.6992.093+0.606
YOY3.0852.884+0.201
5Y3.4293.542-0.113
10Y6.9933.916+3.077
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Jiangxi Fushine Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.403-0.4030%-0.248-38%0.627-164%0.455-188%
Book Value Per Share--4.8904.8900%5.293-8%4.117+19%2.579+90%
Current Ratio--1.7711.7710%1.700+4%1.872-5%1.463+21%
Debt To Asset Ratio--0.4680.4680%0.378+24%0.396+18%0.442+6%
Debt To Equity Ratio--0.8840.8840%0.614+44%0.697+27%0.846+5%
Dividend Per Share--0.0990.0990%0.253-61%0.158-37%0.109-9%
Eps---0.257-0.2570%0.089-390%0.264-197%0.213-221%
Free Cash Flow Per Share---1.055-1.0550%-1.104+5%-0.447-58%-0.191-82%
Free Cash Flow To Equity Per Share---0.540-0.5400%-0.468-13%0.188-388%0.206-362%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.800+25%
Intrinsic Value_10Y_max---6.455--------
Intrinsic Value_10Y_min---18.886--------
Intrinsic Value_1Y_max---0.290--------
Intrinsic Value_1Y_min---1.056--------
Intrinsic Value_3Y_max---1.143--------
Intrinsic Value_3Y_min---3.917--------
Intrinsic Value_5Y_max---2.324--------
Intrinsic Value_5Y_min---7.570--------
Market Cap4961045027.840-46%7260065894.4007260065894.4000%8981581519.360-19%7155795948.017+1%7525613804.588-4%
Net Profit Margin---0.086-0.0860%0.034-351%0.111-177%0.113-176%
Operating Margin---0.036-0.0360%0.144-125%0.173-121%0.161-123%
Operating Ratio--1.7971.7970%1.551+16%1.465+23%1.289+39%
Pb Ratio1.845-46%2.6992.6990%3.085-13%3.429-21%6.993-61%
Pe Ratio-35.067+32%-51.318-51.3180%183.933-128%41.024-225%49.170-204%
Price Per Share9.020-46%13.20013.2000%16.330-19%13.010+1%13.683-4%
Price To Free Cash Flow Ratio-8.550+32%-12.512-12.5120%-14.790+18%157.298-108%4769.996-100%
Price To Total Gains Ratio-29.691+32%-43.450-43.4500%3268.322-101%652.785-107%426.550-110%
Quick Ratio--0.2710.2710%0.446-39%0.352-23%0.408-34%
Return On Assets---0.028-0.0280%0.010-368%0.054-152%0.058-148%
Return On Equity---0.053-0.0530%0.017-411%0.090-159%0.103-151%
Total Gains Per Share---0.304-0.3040%0.005-6180%0.784-139%0.565-154%
Usd Book Value--371169828.888371169828.8880%401760398.575-8%312511291.372+19%195725206.788+90%
Usd Book Value Change Per Share---0.056-0.0560%-0.034-38%0.086-164%0.063-188%
Usd Book Value Per Share--0.6750.6750%0.730-8%0.568+19%0.356+90%
Usd Dividend Per Share--0.0140.0140%0.035-61%0.022-37%0.015-9%
Usd Eps---0.035-0.0350%0.012-390%0.036-197%0.029-221%
Usd Free Cash Flow---80076095.121-80076095.1210%-83804036.976+5%-33931075.538-58%-14476869.613-82%
Usd Free Cash Flow Per Share---0.146-0.1460%-0.152+5%-0.062-58%-0.026-82%
Usd Free Cash Flow To Equity Per Share---0.075-0.0750%-0.065-13%0.026-388%0.028-362%
Usd Market Cap684624213.842-46%1001889093.4271001889093.4270%1239458249.672-19%987499840.826+1%1038534705.033-4%
Usd Price Per Share1.245-46%1.8221.8220%2.254-19%1.795+1%1.888-4%
Usd Profit---19523043.010-19523043.0100%6738631.415-390%20071260.736-197%16177480.603-221%
Usd Revenue--227322352.912227322352.9120%197276916.685+15%195607815.548+16%142708479.529+59%
Usd Total Gains Per Share---0.042-0.0420%0.001-6180%0.108-139%0.078-154%
 EOD+3 -5MRQTTM+0 -0YOY+8 -275Y+10 -2510Y+10 -26

3.2. Fundamental Score

Let's check the fundamental score of Jiangxi Fushine Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-35.067
Price to Book Ratio (EOD)Between0-11.845
Net Profit Margin (MRQ)Greater than0-0.086
Operating Margin (MRQ)Greater than0-0.036
Quick Ratio (MRQ)Greater than10.271
Current Ratio (MRQ)Greater than11.771
Debt to Asset Ratio (MRQ)Less than10.468
Debt to Equity Ratio (MRQ)Less than10.884
Return on Equity (MRQ)Greater than0.15-0.053
Return on Assets (MRQ)Greater than0.05-0.028
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Jiangxi Fushine Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.341
Ma 20Greater thanMa 508.690
Ma 50Greater thanMa 1008.440
Ma 100Greater thanMa 2008.717
OpenGreater thanClose8.710
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Income before Tax  227,077131,282358,35820,453378,811-323,74355,068-197,776-142,707
Net Income  194,725111,110305,83513,465319,300-270,47048,831-190,302-141,471
EBIT  250,412133,293383,705638384,343-178,124206,218-266,289-60,071
Net Income from Continuing Operations  192,362114,518306,88015,299322,179-282,64139,538-203,713-164,175
Net Income Applicable to Common Shares  194,725111,110305,83513,465319,300-270,47048,831-190,302-141,471



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets5,059,834
Total Liabilities2,370,198
Total Stockholder Equity2,681,239
 As reported
Total Liabilities 2,370,198
Total Stockholder Equity+ 2,681,239
Total Assets = 5,059,834

Assets

Total Assets5,059,834
Total Current Assets2,229,278
Long-term Assets2,830,556
Total Current Assets
Cash And Cash Equivalents 978,028
Short-term Investments 49,742
Net Receivables 291,815
Inventory 553,690
Other Current Assets 17,113
Total Current Assets  (as reported)2,229,278
Total Current Assets  (calculated)1,890,387
+/- 338,891
Long-term Assets
Property Plant Equipment 2,201,002
Goodwill 1,147
Intangible Assets 249,708
Other Assets 107,281
Long-term Assets  (as reported)2,830,556
Long-term Assets  (calculated)2,559,137
+/- 271,418

Liabilities & Shareholders' Equity

Total Current Liabilities1,258,857
Long-term Liabilities1,111,341
Total Stockholder Equity2,681,239
Total Current Liabilities
Short Long Term Debt 366,737
Accounts payable 656,667
Other Current Liabilities 185,094
Total Current Liabilities  (as reported)1,258,857
Total Current Liabilities  (calculated)1,208,498
+/- 50,359
Long-term Liabilities
Long term Debt 1,043,044
Other Liabilities 68,297
Long-term Liabilities  (as reported)1,111,341
Long-term Liabilities  (calculated)1,111,341
+/- 0
Total Stockholder Equity
Common Stock550,005
Retained Earnings 881,679
Other Stockholders Equity 16,893
Total Stockholder Equity (as reported)2,681,239
Total Stockholder Equity (calculated)1,448,576
+/- 1,232,663
Other
Capital Stock550,005
Common Stock Shares Outstanding 550,005
Net Debt 431,754
Net Invested Capital 4,091,020
Net Tangible Assets 2,430,385
Net Working Capital 970,421
Property Plant and Equipment Gross 2,201,002



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
> Total Assets 
352,568
472,490
540,670
632,348
1,009,659
1,398,367
1,789,408
2,196,484
2,595,800
4,045,666
4,678,491
5,059,834
5,059,8344,678,4914,045,6662,595,8002,196,4841,789,4081,398,3671,009,659632,348540,670472,490352,568
   > Total Current Assets 
0
0
0
0
627,525
860,577
1,005,913
1,249,264
1,390,045
2,366,664
2,311,556
2,229,278
2,229,2782,311,5562,366,6641,390,0451,249,2641,005,913860,577627,5250000
       Cash And Cash Equivalents 
0
65,586
64,933
62,079
359,785
341,659
612,607
780,702
791,363
1,585,204
1,272,459
978,028
978,0281,272,4591,585,204791,363780,702612,607341,659359,78562,07964,93365,5860
       Short-term Investments 
0
0
13
0
0
170,000
114
0
0
106,676
150,758
49,742
49,742150,758106,67600114170,000001300
       Net Receivables 
59,746
98,054
96,156
119,889
152,194
169,253
184,578
244,192
320,774
201,727
456,216
291,815
291,815456,216201,727320,774244,192184,578169,253152,194119,88996,15698,05459,746
       Other Current Assets 
3,762
3,122
3,440
4,653
4,829
11,541
22,520
12,346
12,268
14,981
15,974
17,113
17,11315,97414,98112,26812,34622,52011,5414,8294,6533,4403,1223,762
   > Long-term Assets 
0
0
0
0
0
537,790
783,495
947,220
1,205,755
1,679,002
2,366,935
2,830,556
2,830,5562,366,9351,679,0021,205,755947,220783,495537,79000000
       Property Plant Equipment 
95,675
166,929
219,131
252,908
303,134
422,680
508,105
662,754
904,193
1,198,529
1,857,016
2,201,002
2,201,0021,857,0161,198,529904,193662,754508,105422,680303,134252,908219,131166,92995,675
       Goodwill 
0
1,147
1,147
1,147
1,147
2,218
4,992
2,218
2,218
2,218
2,218
1,147
1,1472,2182,2182,2182,2184,9922,2181,1471,1471,1471,1470
       Long Term Investments 
0
0
0
0
9,960
13,960
143,960
137,508
0
0
0
0
0000137,508143,96013,9609,9600000
       Intangible Assets 
61,673
65,766
64,417
63,020
60,848
83,805
107,755
102,581
116,509
246,276
256,318
249,708
249,708256,318246,276116,509102,581107,75583,80560,84863,02064,41765,76661,673
       Long-term Assets Other 
0
0
0
0
0
3,076
9,594
33,802
29,373
27,744
51,439
41,502
41,50251,43927,74429,37333,8029,5943,07600000
> Total Liabilities 
232,044
287,886
310,910
349,085
413,445
614,197
822,701
1,049,797
1,068,296
997,927
1,767,184
2,370,198
2,370,1981,767,184997,9271,068,2961,049,797822,701614,197413,445349,085310,910287,886232,044
   > Total Current Liabilities 
184,720
241,344
218,977
276,413
301,785
505,897
675,984
962,015
725,276
884,904
1,359,961
1,258,857
1,258,8571,359,961884,904725,276962,015675,984505,897301,785276,413218,977241,344184,720
       Short-term Debt 
0
0
0
0
29,840
167,000
339,640
585,590
403,426
0
0
0
000403,426585,590339,640167,00029,8400000
       Short Long Term Debt 
0
0
0
0
29,840
167,000
339,640
585,590
403,426
377,383
615,178
366,737
366,737615,178377,383403,426585,590339,640167,00029,8400000
       Accounts payable 
89,783
126,822
117,939
122,711
117,921
172,921
211,942
226,903
241,303
418,600
517,050
656,667
656,667517,050418,600241,303226,903211,942172,921117,921122,711117,939126,82289,783
       Other Current Liabilities 
11,438
9,783
14,948
20,701
5,659
87,442
91,460
65,070
42,027
51,167
142,263
185,094
185,094142,26351,16742,02765,07091,46087,4425,65920,70114,9489,78311,438
   > Long-term Liabilities 
0
0
0
0
0
108,299
146,717
87,782
343,020
113,024
407,223
1,111,341
1,111,341407,223113,024343,02087,782146,717108,29900000
       Long-term Liabilities Other 
0
0
0
0
0
61,786
93,000
37,000
294,308
0
0
0
000294,30837,00093,00061,78600000
       Deferred Long Term Liability 
0
0
0
0
481
910
5,715
9,737
5,771
2,197
0
0
002,1975,7719,7375,7159104810000
> Total Stockholder Equity
120,524
184,604
229,760
283,263
596,214
756,018
936,874
1,116,217
1,489,989
3,007,346
2,880,207
2,681,239
2,681,2392,880,2073,007,3461,489,9891,116,217936,874756,018596,214283,263229,760184,604120,524
   Common Stock
16,000
54,000
54,000
54,000
72,000
112,037
112,310
224,621
273,272
550,005
550,005
550,005
550,005550,005550,005273,272224,621112,310112,03772,00054,00054,00054,00016,000
   Retained Earnings 
104,524
35,235
80,308
133,749
205,751
343,661
465,206
603,776
821,784
1,084,320
1,023,150
881,679
881,6791,023,1501,084,320821,784603,776465,206343,661205,751133,74980,30835,235104,524
   Capital Surplus 000000000000
   Treasury Stock00000-69,194-102,97700000
   Other Stockholders Equity 
0
0
0
0
231
152
545
1,099
101,145
8,344
6,081
16,893
16,8936,0818,344101,1451,0995451522310000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,701,492
Cost of Revenue-1,492,757
Gross Profit208,735208,735
 
Operating Income (+$)
Gross Profit208,735
Operating Expense-1,763,181
Operating Income-61,690-1,554,447
 
Operating Expense (+$)
Research Development85,154
Selling General Administrative71,429
Selling And Marketing Expenses-
Operating Expense1,763,181156,583
 
Net Interest Income (+$)
Interest Income35,841
Interest Expense-42,577
Other Finance Cost-37,374
Net Interest Income-44,110
 
Pretax Income (+$)
Operating Income-61,690
Net Interest Income-44,110
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-273,256-61,690
EBIT - interestExpense = -42,577
-269,009
-226,432
Interest Expense42,577
Earnings Before Interest and Taxes (EBIT)--230,678
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-273,256
Tax Provision-11,419
Net Income From Continuing Ops-284,675-284,675
Net Income-269,009
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-44,110
 

Technical Analysis of Fushine
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Fushine. The general trend of Fushine is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Fushine's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Jiangxi Fushine Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 9.8 < 11.10 < 11.27.

The bearish price targets are: 7.44 > 5.62.

Tweet this
Jiangxi Fushine Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Jiangxi Fushine Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Jiangxi Fushine Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Jiangxi Fushine Pharmaceutical Co Ltd. The current macd is -0.09066675.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Fushine price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Fushine. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Fushine price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Jiangxi Fushine Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartJiangxi Fushine Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Jiangxi Fushine Pharmaceutical Co Ltd. The current adx is 27.86.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Fushine shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Jiangxi Fushine Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Jiangxi Fushine Pharmaceutical Co Ltd. The current sar is 7.4656.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Jiangxi Fushine Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Jiangxi Fushine Pharmaceutical Co Ltd. The current rsi is 57.34. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Jiangxi Fushine Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartJiangxi Fushine Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Jiangxi Fushine Pharmaceutical Co Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Fushine price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Jiangxi Fushine Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartJiangxi Fushine Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Jiangxi Fushine Pharmaceutical Co Ltd. The current cci is 32.11.

Jiangxi Fushine Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartJiangxi Fushine Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Jiangxi Fushine Pharmaceutical Co Ltd. The current cmo is 24.39.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Jiangxi Fushine Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartJiangxi Fushine Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Jiangxi Fushine Pharmaceutical Co Ltd. The current willr is -13.66120219.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Jiangxi Fushine Pharmaceutical Co Ltd Daily Williams %R ChartJiangxi Fushine Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Jiangxi Fushine Pharmaceutical Co Ltd.

Jiangxi Fushine Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Jiangxi Fushine Pharmaceutical Co Ltd. The current atr is 0.40896363.

Jiangxi Fushine Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartJiangxi Fushine Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Jiangxi Fushine Pharmaceutical Co Ltd. The current obv is -64,704,438.

Jiangxi Fushine Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartJiangxi Fushine Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Jiangxi Fushine Pharmaceutical Co Ltd. The current mfi is 43.83.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Jiangxi Fushine Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartJiangxi Fushine Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Jiangxi Fushine Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-10MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-06MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-06MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-17MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Jiangxi Fushine Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Jiangxi Fushine Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.341
Ma 20Greater thanMa 508.690
Ma 50Greater thanMa 1008.440
Ma 100Greater thanMa 2008.717
OpenGreater thanClose8.710
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Fushine with someone you think should read this too:
  • Are you bullish or bearish on Fushine? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Fushine? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Jiangxi Fushine Pharmaceutical Co Ltd

I send you an email if I find something interesting about Jiangxi Fushine Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Jiangxi Fushine Pharmaceutical Co Ltd.

Receive notifications about Jiangxi Fushine Pharmaceutical Co Ltd in your mailbox!